NCT02352285 - Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Heart Failure With Hyponatremia

Interventions

DRUG

Tolvaptan

Start with 15mg to titrate upwards to 30mg to 60mg, once a daily

DRUG

Placebo

Start with 15mg to titrate upwards to 30mg to 60mg, once a daily

Trial Locations (1)

Seoul National University Bundang Hospital, Seoul